Public deck

Thermo Fisher: Can inorganic M&A growth sustain the premium earnings multiple today?

Thermo Fisher's acquisition engine is still powerful, but Q1 2026 showed why the premium-multiple debate needs a harder evidence gate: 6% reported revenue growth, 1% organic growth, a major Clario acquisition, higher debt and a larger goodwill/intangible asset base.